Related Experiment Video
Updated: Jun 22, 2025

Intracerebroventricular Treatment with Resiniferatoxin and Pain Tests in Mice
Published on: September 2, 2020
TRPV1 Channels in the Central Nervous System as Drug Targets
1School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW 2308, Australia.
TRPV1 channel antagonists show promise for pain relief by targeting specific pathways. Further research is needed to understand TRPV1 channels in the central nervous system for neurological and psychiatric treatments.
Area of Science:
- Neuroscience
- Pharmacology
- Pain Research
Background:
- Transient Receptor Potential Vanilloid 1 (TRPV1) channels are key players in pain and thermal sensation.
- TRPV1 antagonists are explored for pain management but face challenges with side effects like altered thermal homeostasis.
- TRPV1 channels are also found in the central nervous system (CNS), influencing cognition and behavior.
Purpose of the Study:
- To explore the potential of developing TRPV1 antagonists that alleviate pain without compromising heat sensation.
- To investigate the role of TRPV1 channels in the CNS for potential therapeutic applications.
Main Methods:
- Review of recent studies on TRPV1 channel function and pharmacology.
- Analysis of findings related to TRPV1 antagonist efficacy and side effect profiles.
- Examination of evidence linking TRPV1 channels to CNS functions.
Main Results:
- TRPV1 antagonists may offer a way to achieve analgesia without disrupting thermal regulation.
- TRPV1 channels in the CNS are implicated in learning, memory, and behavior.
Conclusions:
- Developing selective TRPV1 antagonists for pain relief is feasible.
- Further investigation into TRPV1 channel function within the CNS is crucial for advancing treatments for neurological and psychiatric disorders.
More Related Videos
12:09Yeast Luminometric and Xenopus Oocyte Electrophysiological Examinations of the Molecular Mechanosensitivity of TRPV4
Published on: December 31, 2013
10:20Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b
Published on: November 11, 2016
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Neurochemical Transmission: Sites of Drug Action
Mechanically-gated Ion Channels
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...